The aggregation mechanism of phosphorylated tau is an important therapeutic target for tauopathies, including Alzheimer’s disease, although the mechanism by which aggregation occurs is still unknown. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.